Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Longer-Term Safety of Fostamatinib (R788) in Patients with Rheumatoid Arthritis-Analysis of Clinical Trial Data From up to 2 Years of Exposure. Kavanaugh, A., Weinblatt, M. E., Genovese, M. C., Musser, T. K., Grossbard, E. B., Magilavy, D. B., Hollis, S., van-Sway, E., Millson, D. WILEY-BLACKWELL. 2011: S1018–S1019
View details for Web of Science ID 000297621503174